ClinicalTrials.govpublic full text
Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1
nephrotic syndrome, focal segmental glomerulosclerosis, apol1 associated kidney disease, covid-19 associated nephropathy, human immunodeficiency virus associated nephropathy, minimal change disease, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810761
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.